Search
Search results for: SURVIVIN
Found little results, maybe try searching with alternative method.
Search results for: SURVIVIN
-
Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
Publication -
Survivin splice variants expression in thyroid malignancy
Publication -
Evaluation of survivin splice variants in pituitary tumors
Publication -
Survivin Delta Ex3 Overexpression in Thyroid Malignancies
Publication -
Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level
Publication -
Survivin expression in invasive pituitary gland adenomas with a diameter exceeding 20 mm
Publication -
Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
Publication -
Are Radiosensitive and Regular Response Cells Homogeneous in Their Correlations Between Copy Number State and Surviving Fraction After Irradiation?
Publication -
Targeting of FLT3-ITD kinase contributes to high selectivity of imidazoacridinone C-1311 against FLT3-activated leukemia cells
PublicationDrugs targeting receptor tyrosine kinase FLT3 are of particular interest since activating FLT3-internal tandem duplication (ITD) mutations abundantly occur in fatal acute myeloid leukemias (AMLs). Imidazoacridinone C-1311, a DNA-reactive inhibitor of topoisomerase II, has been previously shown to be a potent and selective inhibitor of recombinant FLT3. Here, we expand those findings by studying its effect on leukemia cells with...